Use of cephalosporins in acute rhinosinusitis in outpatient practice
https://doi.org/10.21518/2079-701X-2016-6-74-77
Abstract
In recent years, the term "rhinosinusitis" has become commonly used. It unites a group of inflammatory diseases of the nasal cavity and paranasal sinuses, since it was proved that inflammation of the nasal mucous membrane invariably involves mucosa of the paranasal sinuses.
About the Authors
A. I. Kryukov
Research and Clinical Otorhinolaryngology Institute named after L.I. Sverzhevskiy
Russian Federation
Russian Federation
A. Y. Ovchinnikov
Moscow State University of Medicine and Dentistry named after A.I. Evdokimov
Russian Federation
Russian Federation
N. A. Miroshnichenko
Moscow State University of Medicine and Dentistry named after A.I. Evdokimov
Russian Federation
Russian Federation
G. B. Shagramanayn
Moscow State University of Medicine and Dentistry named after A.I. Evdokimov
Russian Federation
Russian Federation
I. V. Smirnov
Moscow State University of Medicine and Dentistry named after A.I. Evdokimov
Russian Federation
Russian Federation
References
1. Fokkens WJ, Lund VJ, Mullol J et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. Rhinology, 2012, 50(1): 1-12.
2. Chow AW, Benninger MS, Brook I et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis, 2012, 54(8): 72-112.
3. Крюков А.И., Студеный М.Е., Артемьев М.Е. и др. Лечение пациентов с риносинуситами: возможности консервативного и оперативного воздействия. Медицинский совет, 2012, 11.
4. Отвагин И.В. Фармакоэпидемиологическое и клинико-бактериологическое обоснование применения цефалоспоринов у больных острым синуситом: Автореф. дис. … канд. мед. наук. Смоленск, 1998. 22 с.
5. Рязанцев С.В. Принципы этиопатогенетической терапии острых синуситов (метод.реком.). СПб., 2013. 40 с.
6. Страчунский Л.С., Тарасов А.А., Крюков А.И. с соавт. Возбудители острого бактериального риносинусита. Результаты многоцентрового микробиологического исследования SSSR. Клиническая микробиология и антимикробная химиотерапия, 2005, 7(4): 337-349.
7. Hansen JG, Schmidt H, Rosborg J, Lund E. Predicting acute maxillary sinusitis in a general practice population. BMJ, 1995, 311: 233-236.
8. Kryukov A.I., Studeny M.E., Artemyev M.E. et al. Treatment of patients with rhinosinusitis: prospects for conservative and surgical impact. Meditsinskiy Sovet, 2012, 11.
9. Otvagin I.V. Pharmacoepidemiological and bacteriological rationale for the use of cephalosporins in patients with acute sinusitis: Abstract of thesis for PhD in medicine. Smolensk, 1998. 22 p.
10. Ryazantsev S.V. The principles of etiopathogenetic treatment of acute sinusitis (guidelines). SPb., 2013. 40 p.
11. Strachunskiy L.S., Tarasov A.A., Kryukov A.I. et al. Causative agents of acute bacterial rhinosinusitis. Results of the SSSR multicenter microbiological trial. Klinicheskaya i Antimikrobnaya Khimioterapiya, 2005, 7 (4): 337-349
Review
For citations:
Kryukov AI, Ovchinnikov AY, Miroshnichenko NA, Shagramanayn GB, Smirnov IV. Use of cephalosporins in acute rhinosinusitis in outpatient practice. Meditsinskiy sovet = Medical Council. 2016;(6):74-77. (In Russ.) https://doi.org/10.21518/2079-701X-2016-6-74-77
Views:
571
Email this article 